Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04861740 · ClinicalTrials.gov registry record · NA
Autism Access Link for Early Referral and Treatment
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT04861740 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 148 participants.
The verdict
NCT04861740, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
Autism Access Link for Early Referral and Treatment \[ALERT\], the intervention proposed in this application, is a novel state-wide referral and case management platform that PCPs can activate to ensure that a child with suspected ASD receives all necessary ASD diagnosis and treatment resources in a single referral, radically simplifying a complex diagnostic and treatment process. We hypothesize that Autism ALERT will have strong acceptability and high rates of use among primary care providers as well as among diverse low-income patients of children at risk for ASD, and that we will see higher rates of child ASD educational evaluations within six months, and shorter time between referral and ASD treatment, compared with our control.
Interventions
- OTHER Autism ALERT
- OTHER Screening Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2024-01-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04861740
The ClinicalTrials.gov registry entry for NCT04861740 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Autism ALERT is the first listed.
NCT04861740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04861740 about?
NCT04861740 is a clinical study titled "Autism Access Link for Early Referral and Treatment". Autism Access Link for Early Referral and Treatment \[ALERT\], the intervention proposed in this application, is a novel state-wide referral and case management platform that PCPs can activate to ensure that a child with suspected ASD receives all necessary ASD diagnosis and treatment resources in a...
What is the current status of trial NCT04861740?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2020-09-01. Estimated completion is 2024-01-04.
What interventions are being tested in trial NCT04861740?
The interventions under investigation include: Autism ALERT (OTHER), Screening Intervention (OTHER).
Who is sponsoring clinical trial NCT04861740?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.